← FDA Drug Approvals (Drugs@FDA)

VEOPOZ

BLA · Biologics License Application · Sponsor: REGENERON PHARMACEUTICALS · Approved 2023-08-18

Drug application

FDA Application #

BLA761339

Application type

Biologics License Application

Brand name

VEOPOZ

Generic name

POZELIMAB

Active ingredients

POZELIMAB-BBFG

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

REGENERON PHARMACEUTICALS

Manufacturer

Regeneron Pharmaceuticals, Inc.

First approval

2023-08-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown